Rapid roll out of SARS-CoV-2 antibody testing-a concern.

Authors :: Andersson M
Low N
French N
Greenhalgh T
Jeffery K
Brent A
Ball J
Pollock A
McCoy D
Iturriza-Gomara M
Buchan I
Salisbury H
Pillay D
Irving W
Source :: BMJ (Clinical research ed.) [BMJ] 2020 Jun 24; Vol. 369, pp. m2420. Date of Electronic Publication: 2020 Jun 24.
Publication Year :: 2020
Abstract: Competing Interests: Competing interests: IB: chief data scientist adviser for AstraZeneca through the University of Liverpool. WI: speaker and consultancy fees from Roche, Janssen Cilag, Gilead Sciences, and Novartis; educational grants from Boehringer Ingelheim, Merck Sharp and Dohme, and Gilead Sciences; and research grant support from GlaxoSmithKline, Pfizer, Gilead Sciences, Janssen Cilag, Abbvie, and Bristol-Myers Squibb. All other authors: none declared.